Ablation by three-dimensional electroanatomical mapping versus anti-arrhythmic drug therapy: a cost-utility analysis in the treatment of idiopathic ventricular arrhythmias.

ABSTRACT:

Aim

To assess the cost-utility of ablation guided by three-dimensional electroanatomical mapping (3DEAM) with antiarrhythmic drug (AAD) therapy in the management of patients with idiopathic ventricular arrhythmias (IVA) at a highly specialized cardiovascular center in Peru.

Methods

A cost-utility economic evaluation was conducted in a public institution involving patients diagnosed with IVAs between 2017 and 2022. The analysis included projections adjusted according to life expectancy. Cost analysis was performed from the payer's perspective (public health insurance) using the macro-cost estimation methodology and applying a 9.6% discount rate. Utility values were derived from the SF-36 questionnaire, facilitating the calculation of average quality-adjusted life years (QALYs

SUBMITTER: Soto-Becerra R 

PROVIDER: S-EPMC11963419 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature